Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challenge

References

• Butler D. Zika virus: Brazil’s surge in small-headed babies questioned by report. Nature. 2016;530:13–14. doi:10.1038/nature.2016.19259.
   PubMed Web of Science ®Google Scholar
• Musso D, Baud D. Zika virus: time to move from case reports to case control. Lancet Infect Dis. 2016. doi:10.1016/S1473-3099(16)00096-7.
   Google Scholar
• Samarasekera U, Triunfol M. Concern over Zika virus grips the world. Lancet. 2016;387:521–24. doi:10.1016/S0140-6736(16)00257-9.
   PubMed Web of Science ®Google Scholar
• Bogoch II, Brady OJ, Kraemer MU, German M, Creatore MI, Kulkarni MA, Brownstein JS, Mekaru SR, Hay SI, Groot E, et al. Anticipating the international spread of Zika virus from Brazil. Lancet. 2016;387:335–36. doi:10.1016/S0140-6736(16)00080-5.
   PubMed Web of Science ®Google Scholar
• Enfissi A, Codrington J, Roosblad J, Kazanji M, Rousset D. Zika virus genome from the Americas. Lancet. 2016;387:227–28. doi:10.1016/S0140-6736(16)00003-9.
   PubMed Web of Science ®Google Scholar
• Ma W, Li S, Ma S, Jia L, Zhang F, Zhang Y, Zhang J, Wong G, Zhang S, Lu X, et al. Zika virus causes testis damage and leads to male infertility in mice. Cell. 2017;168:542. doi:10.1016/j.cell.2017.01.009.
   PubMed Web of Science ®Google Scholar
• Griffin BD, Muthumani K, Warner BM, Majer A, Hagan M, Audet J, Stein DR, Ranadheera C, Racine T, De La Vega MA, et al. DNA vaccination protects mice against Zika virus-induced damage to the testes. Nat Commun. 2017;8:15743. doi:10.1038/ncomms15743.
   PubMed Web of Science ®Google Scholar
• Rubin EJ, Greene MF, Baden LR. Zika virus and microcephaly. N Engl J Med. 2016. doi:10.1056/NEJMe1601862.
   Google Scholar
• Roa M. Zika virus outbreak: reproductive health and rights in Latin America. Lancet. 2016. doi:10.1016/S0140-6736(16)00331-7.
   PubMed Web of Science ®Google Scholar
• Lucey DR, Gostin LO. The emerging Zika pandemic: enhancing preparedness. JAMA. 2016. doi:10.1001/jama.2016.0904.
   Web of Science ®Google Scholar
• Tebas P, Roberts CC, Muthumani K, Reuschel EL, Kudchodkar SB, Zaidi FI, White S, Khan AS, Racine T, Choi H, et al. Safety and Immunogenicity of an anti–Zika virus DNA vaccine — preliminary report. N Engl J Med. 2017. doi:10.1056/NEJMoa1708120.
   Google Scholar
• Muthumani K, Griffin BD, Agarwal S, Kudchodkar SB, Reuschel EL, Choi H, Kraynyak KA, Duperret EK, Keaton AA, Chung C, et al. In vivo protection against ZIKV infection and pathogenesis through passive antibody transfer and active immunisation with a prMEnv DNA vaccine. NPJ Vaccines. 2016;1:16021. doi:10.1038/npjvaccines.2016.21.
   PubMed Web of Science ®Google Scholar
• Pardi N, Hogan MJ, Pelc RS, Muramatsu H, Andersen H, DeMaso CR, Dowd KA, Sutherland LL, Scearce RM, Parks R, et al. Zika virus protection by a single low-dose nucleoside-modified mRNA vaccination. Nature. 2017;543:248–51. doi:10.1038/nature21428.
   PubMed Web of Science ®Google Scholar
• Larocca RA, Abbink P, Peron JP, Zanotto PM, Iampietro MJ, Badamchi-Zadeh A, Boyd M, Ng’ang’a D, Kirilova M, Nityanandam R, et al. Vaccine protection against Zika virus from Brazil. Nature. 2016;536:474–78. doi:10.1038/nature18952.
   PubMed Web of Science ®Google Scholar
• Boigard H, Alimova A, Martin GR, Katz A, Gottlieb P, Galarza JM. Zika virus-like particle (VLP) based vaccine. PLoS Negl Trop Dis. 2017;11:e0005608. doi:10.1371/journal.pntd.0005608.
   PubMed Web of Science ®Google Scholar
• Abbink P, Larocca RA, De La Barrera RA, Bricault CA, Moseley ET, Boyd M, Kirilova M, Li Z, Nganga D, Nanayakkara O, et al. Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science. 2016;353:1129–32. doi:10.1126/science.aah6157.
   PubMed Web of Science ®Google Scholar
• Patel A, DiGiandomenico A, Keller AE, Smith TRF, Park DH, Ramos S, Schultheis K, Elliott STC, Mendoza J, Broderick KE, et al. An engineered bispecific DNA-encoded IgG antibody protects against Pseudomonas aeruginosa in a pneumonia challenge model. Nat Commun. 2017;8:637. doi:10.1038/s41467-017-00576-7.
   PubMed Web of Science ®Google Scholar
• Flingai S, Plummer EM, Patel A, Shresta S, Mendoza JM, Broderick KE, Sardesai NY, Muthumani K, Weiner DB. Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy. Sci Rep. 2015;5:12616. doi:10.1038/srep12616.
   PubMed Web of Science ®Google Scholar
• Muthumani K, Block P, Flingai S, Muruganantham N, Chaaithanya IK, Tingey C, Wise M, Reuschel EL, Chung C, Muthumani A, et al. Rapid and long-term immunity elicited by DNA encoded antibody prophylaxis and DNA vaccination against Chikungunya virus. J Infect Dis. 2016. doi:10.1093/infdis/jiw111.
   PubMed Web of Science ®Google Scholar
• Elliott STC, Kallewaard NL, Benjamin E, Wachter-Rosati L, McAuliffe JM, Patel A, Smith TRF, Schultheis K, Park DH, Flingai S, et al. DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infections. NPJ Vaccines. 2017;2:18.
   PubMed Web of Science ®Google Scholar
• Ostertag EM, Kacir S, Thiboutot M, Gulendran G, Zheng XL, Cines DB, Siegel DL. ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 1. Structural and functional characterization in vitro. Transfusion. 2016;56:1763–74. doi:10.1111/trf.13584.
   PubMed Web of Science ®Google Scholar
• Andris-Widhopf J, Steinberger P, Fuller R, Rader C, Barbas CF 3rd. Generation of human Fab antibody libraries: PCR amplification and assembly of light- and heavy-chain coding sequences. Cold Spring Harb Protoc. 2011 Sep 1;2011(9).
   Google Scholar
• Payne AS, Ishii K, Kacir S, Lin C, Li H, Hanakawa Y, Tsunoda K, Amagai M, Stanley JR, Siegel DL, et al. Genetic and functional characterization of human pemphigus vulgaris monoclonal autoantibodies isolated by phage display. J Clin Invest. 2005;115:888–99. doi:10.1172/JCI24185.
   PubMed Web of Science ®Google Scholar
• Wise MC, Hutnick NA, Pollara J, Myles DJ, Williams C, Yan J, LaBranche CC, Khan AS, Sardesai NY, Montefiori D, et al. An enhanced synthetic multiclade DNA prime induces improved cross-clade-reactive functional antibodies when combined with an adjuvanted protein boost in nonhuman primates. J Virol. 2015;89:9154–66. doi:10.1128/JVI.00652-15.
   PubMed Web of Science ®Google Scholar
• Barouch DH, Thomas SJ, Michael NL. Prospects for a Zika virus vaccine. Immunity. 2017;46:176–82. doi:10.1016/j.immuni.2017.02.005.
   PubMed Web of Science ®Google Scholar
• Barba-Spaeth G, Dejnirattisai W, Rouvinski A, Vaney MC, Medits I, Sharma A, Simon-Lorière E, Sakuntabhai A, Cao-Lormeau VM, Haouz A, et al. Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature. 2016 Aug 4;536(7614):48–53.
   Web of Science ®Google Scholar
• Tebas P, Roberts CC, Muthumani K, Reuschel EL, Kudchodkar SB, Zaidi FI, White S, Khan AS, Racine T, Choi H, et al. Safety and Immunogenicity of an anti-Zika virus DNA vaccine - preliminary report. N Engl J Med. 2017. doi:10.1056/NEJMoa1708120.
   Web of Science ®Google Scholar
• Shan C, Muruato AE, Nunes BTD, Luo H, Xie X, Medeiros DBA, Wakamiya M, Tesh RB, Barrett AD, Wang T, et al. A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models. Nat Med. 2017;23:763–67. doi:10.1038/nm.4322.
   PubMed Web of Science ®Google Scholar
• Brochet X, Lefranc MP, Giudicelli V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 2008;36:W503–8. doi:10.1093/nar/gkn316.
   PubMed Web of Science ®Google Scholar
• Stettler K, Beltramello M, Espinosa DA, Graham V, Cassotta A, Bianchi S, Vanzetta F, Minola A, Jaconi S, Mele F, et al. Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science. 2016;353:823–26. doi:10.1126/science.aaf8505.
   PubMed Web of Science ®Google Scholar
• Dai L, Song J, Lu X, Deng Y-Q, Musyoki AM, Cheng H, Zhang Y, Yuan Y, Song H, Haywood J, et al. Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody. Cell Host Microbe. 2016;19:696–704. doi:10.1016/j.chom.2016.04.013.
   PubMed Web of Science ®Google Scholar
• Zhao H, Fernandez E, Dowd KA, Speer SD, Platt DJ, Gorman MJ, Govero J, Nelson CA, Pierson TC, Diamond MS, et al. Structural basis of Zika virus-specific antibody protection. Cell. 2016;166:1016–27. doi:10.1016/j.cell.2016.07.020.
   PubMed Web of Science ®Google Scholar
• Muthumani K, Falzarano D, Reuschel EL, Tingey C, Flingai S, Villarreal DO, Wise M, Patel A, Izmirly A, Aljuaid A, et al. A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates. Sci Transl Med. 2015;7:301ra132. doi:10.1126/scitranslmed.aac7462.
   PubMed Web of Science ®Google Scholar
• Lazear HM, Govero J, Smith AM, Platt DJ, Fernandez E, Miner JJ, Diamond M. a mouse model of Zika virus pathogenesis. Cell Host Microbe. 2016;19:720–30. doi:10.1016/j.chom.2016.03.010.
   PubMed Web of Science ®Google Scholar
• Wang J, Bardelli M, Espinosa DA, Pedotti M, Ng T-S, Bianchi S, Simonelli L, Lim EXY, Foglierini M, Zatta F, et al. A human bi-specific antibody against Zika virus with high therapeutic potential. Cell. 2017;171:229–41 e15. doi:10.1016/j.cell.2017.09.002.
   PubMed Web of Science ®Google Scholar
• Dowd KA, DeMaso CR, Pelc RS, Speer SD, Smith ARY, Goo L, Platt DJ, Mascola JR, Graham BS, Mulligan MJ, et al. Broadly neutralizing activity of Zika virus-immune sera identifies a single viral serotype. Cell Rep. 2016 Aug 9;16(6):1485–91. doi:10.1016/j.celrep.2016.07.049.
   Web of Science ®Google Scholar
• Wilder-Smith A, Vannice K, Durbin A, Hombach J, Thomas SJ, Thevarjan I, Simmons CP. Zika vaccines and therapeutics: landscape analysis and challenges ahead. BMC Med. 2018;16:84. doi:10.1186/s12916-018-1067-x.
   PubMed Web of Science ®Google Scholar
• Cao-Lormeau VM, Blake A, Mons S, Lastere S, Roche C, Vanhomwegen J, Dub T, Baudouin L, Teissier A, Larre P, et al. Guillain–Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 2016;387:1531–39. doi:10.1016/S0140-6736(16)00562-6.
   PubMed Web of Science ®Google Scholar
• Perales-Puchalt A, Wojtak K, Duperret EK, Yang X, Slager AM, Yan J, Muthumani K, Montaner LJ, Weiner DB. Engineered DNA vaccination against follicle-stimulating hormone receptor delays ovarian cancer progression in animal models. Mol Ther. 2019 Feb 6;27(2):314–25. doi:10.1016/j.ymthe.2018.11.014.
   Web of Science ®Google Scholar
• Perales-Puchalt A, Duperret EK, Yang X, Hernandez P, Wojtak K, Zhu X, Jung SH, Tello-Ruiz E, Wise MC, Montaner LJ. DNA-encoded bispecific T cell engagers and antibodies present long-term antitumor activity. JCI Insight. 2019 Apr 18;4(8).
   Web of Science ®Google Scholar
• Zimmerman MG, Quicke KM, O’Neal JT, Arora N, Machiah D, Priyamvada L, Kauffman RC, Register E, Adekunle O, Swieboda D, et al. Cross-reactive dengue virus antibodies augment Zika virus infection of human placental macrophages. Cell Host Microbe. 2018;24:731–42 e6. doi:10.1016/j.chom.2018.10.008.
   PubMed Web of Science ®Google Scholar
• Rana J, Slon Campos JL, Leccese G, Francolini M, Bestagno M, Poggianella M, Burrone OR. Role of capsid anchor in the morphogenesis of Zika virus. J Virol. 2018 Oct 29;92(22).
   Web of Science ®Google Scholar
• Lin SR, Zou G, Hsieh SC, Qing M, Tsai WY, Shi PY, Wang W-K. The helical domains of the stem region of dengue virus envelope protein are involved in both virus assembly and entry. J Virol. 2011;85:5159–71. doi:10.1128/JVI.02099-10.
   PubMed Web of Science ®Google Scholar
• Esquivel RN, Patel A, Kudchodkar SB, Park DH, Stettler K, Beltramello M, Allen JW, Mendoza J, Ramos S, Choi H, et al. In Vivo delivery of a DNA-encoded monoclonal antibody protects non-human primates against Zika virus. Mol Ther. 2019;27:974–85. doi:10.1016/j.ymthe.2019.03.005.
   PubMed Web of Science ®Google Scholar
• Beaver JT, Lelutiu N, Habib R, Skountzou I. Evolution of two major Zika virus lineages: implications for pathology, immune response, and vaccine development. Front Immunol. 2018;9:1640. doi:10.3389/fimmu.2018.01640.
   PubMed Web of Science ®Google Scholar